213P Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe
| Autor: | Oikonomidou, O., Galve-Calvo, E., Wöckel, A., Parikh, R., Hitchens, A., Chen, C., Gauthier, E., Li, B., Ansquer, V. Derrien, Frugier, G., Jimenez, M., Davis, K., Broughton, E. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|